Merck & Co., Inc. announced today that Darryle D. Schoepp, Ph.D. has been named senior vice president and franchise head, Neuroscience, Merck Research Laboratories (MRL). Dr. Schoepp assumes his new role on March 5th and will report to Peter S. Kim, Ph.D., president, MRL.

Merck & Co., Inc. announced today that Luciano Rossetti, M.D., has been named senior vice president and franchise head, Diabetes and Obesity, Merck Research Laboratories (MRL). Dr. Rossetti assumes his new role on Sept. 1 and will report to Peter S. Kim, Ph.D., president, MRL.

Merck & Co., Inc. announced today that R. Alan B. Ezekowitz, MBChB, D.Phil., has been named senior vice president and franchise head, Immunology, Respiratory and Endocrine, Merck Research Laboratories (MRL). Dr. Ezekowitz assumes his new role on April 1 and will report to Peter S.

Sumitomo Pharmaceuticals Co., Ltd. and Merck & Co., Inc.

WASHINGTON -- Vioxx could go back on sale if the government finds that heart and stroke problems linked to the arthritis drug are not unique to the painkiller and that the medication's benefits outweigh the risks, a company executive suggested Thursday.